Wayne Langholff

3.3k total citations · 1 hit paper
70 papers, 2.4k citations indexed

About

Wayne Langholff is a scholar working on Immunology, Small Animals and Economics and Econometrics. According to data from OpenAlex, Wayne Langholff has authored 70 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 16 papers in Small Animals and 15 papers in Economics and Econometrics. Recurrent topics in Wayne Langholff's work include Psoriasis: Treatment and Pathogenesis (25 papers), Helminth infection and control (16 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Wayne Langholff is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (25 papers), Helminth infection and control (16 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Wayne Langholff collaborates with scholars based in United States, Canada and Netherlands. Wayne Langholff's co-authors include Bruce Salzberg, Russell D. Cohen, William J. Sandborn, Brian G. Feagan, Robert H. Diamond, Anil Londhe, Kavitha Goyal, Gary R. Lichtenstein, Steven Fakharzadeh and Stephen Calabro and has published in prestigious journals such as Gastroenterology, Spine and Critical Care Medicine.

In The Last Decade

Wayne Langholff

68 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

2012 563 citations Gary R. Lichtenstein, Brian G. Feagan et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wayne Langholff United States	22	1.0k	739	640	397	292	70	2.4k
Charles B. Foster United States	26	1.6k 1.5×	433 0.6×	851 1.3×	48 0.1×	195 0.7×	64	3.6k
Hok Bing Thio Netherlands	27	1.0k 1.0×	136 0.2×	451 0.7×	750 1.9×	234 0.8×	72	2.5k
Andrew S. Kemp Australia	35	668 0.6×	122 0.2×	531 0.8×	1.1k 2.7×	93 0.3×	100	3.9k
Zsolt Szépfalusi Austria	36	670 0.6×	159 0.2×	309 0.5×	957 2.4×	168 0.6×	148	4.1k
Uma Mahadevan United States	27	852 0.8×	1.2k 1.7×	812 1.3×	77 0.2×	101 0.3×	92	2.5k
Ulrich Baumann Germany	35	584 0.6×	393 0.5×	1.7k 2.7×	146 0.4×	108 0.4×	149	4.5k
Hien Q. Huynh Canada	27	450 0.4×	796 1.1×	560 0.9×	25 0.1×	131 0.4×	106	2.3k
Orathai Jirapongsananuruk Thailand	25	550 0.5×	122 0.2×	174 0.3×	451 1.1×	189 0.6×	118	2.2k
George Ν. Dalekos Greece	39	295 0.3×	250 0.3×	3.2k 5.0×	52 0.1×	542 1.9×	207	4.8k
Séamus Hussey Ireland	23	788 0.8×	698 0.9×	911 1.4×	74 0.2×	30 0.1×	67	2.8k

Countries citing papers authored by Wayne Langholff

Since Specialization

Citations

This map shows the geographic impact of Wayne Langholff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Langholff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Langholff more than expected).

Fields of papers citing papers by Wayne Langholff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Langholff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Langholff. The network helps show where Wayne Langholff may publish in the future.

Co-authorship network of co-authors of Wayne Langholff

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Langholff. A scholar is included among the top collaborators of Wayne Langholff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Langholff. Wayne Langholff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schechtman, Joy, Alan Kivitz, Natalie J. Shiff, et al.. (2023). Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study. BMC Rheumatology. 7(1). 5–5. 1 indexed citations

Schreiber, S, C. Janneke van der Woude, Ignacio Marín‐Jiménez, et al.. (2023). P436 Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn’s disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial. Journal of Crohn s and Colitis. 17(Supplement_1). i564–i566. 8 indexed citations

Lee, Scott D., Stefan Schreiber, C. Janneke van der Woude, et al.. (2023). 1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL. Gastroenterology. 164(6). S–220. 3 indexed citations

Takeshita, Junko, Matthias Augustin, E.M.G.J. de Jong, et al.. (2022). Health-Related QOL Differs by Race/Ethnicity in North American Patients with Psoriasis: Results from PSOLAR. Journal of Investigative Dermatology. 142(9). 2528–2531.e3. 5 indexed citations

Langley, Richard G., Yves Poulin, Bhaskar Srivastava, et al.. (2020). Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis. Journal of the American Academy of Dermatology. 84(1). 60–69. 15 indexed citations

Ritchlin, Christopher T., Mona Ståhle, Yves Poulin, et al.. (2019). Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics. BMC Rheumatology. 3(1). 52–52. 25 indexed citations

Takeshita, Junko, Matthias Augustin, E.M.G.J. de Jong, et al.. (2019). 857 Psoriasis-related quality-of-life differs by race/ethnicity. Journal of Investigative Dermatology. 139(5). S148–S148. 2 indexed citations

Lichtenstein, Gary R., Brian G. Feagan, Uma Mahadevan, et al.. (2018). Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. The American Journal of Gastroenterology. 113(11). 1678–1688. 44 indexed citations

Strober, Bruce, Melinda Gooderham, E.M.G.J. de Jong, et al.. (2017). Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal of the American Academy of Dermatology. 78(1). 70–80. 85 indexed citations

10.

Lichtenstein, Gary R., Brian G. Feagan, Russell D. Cohen, et al.. (2012). Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry. The American Journal of Gastroenterology. 107(9). 1409–1422. 563 indexed citations breakdown →

11.

Arroliga, Alejandro C., et al.. (2009). Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss*. Critical Care Medicine. 37(4). 1299–1307. 17 indexed citations

12.

Napolitano, Lena M., Timothy C. Fabian, Kathleen Kelly, et al.. (2008). Improved Survival of Critically Ill Trauma Patients Treated With Recombinant Human Erythropoietin. The Journal of Trauma: Injury, Infection, and Critical Care. 65(2). 285–299. 56 indexed citations

13.

Scott, Graham, Christine Reynolds, Slavica Milosavljev, et al.. (2004). Lack of Effect of Omeprazole or of an Aluminium Hydroxide/Magnesium Hydroxide Antacid on the Pharmacokinetics of Lumiracoxib. Clinical Pharmacokinetics. 43(5). 341–348. 10 indexed citations

14.

Klei, Thomas R., Steffen Rehbein, Martin Visser, et al.. (2001). Re-evaluation of ivermectin efficacy against equine gastrointestinal parasites. Veterinary Parasitology. 98(4). 315–320. 34 indexed citations

15.

Rehbein, Steffen, et al.. (2000). Effects of Psoroptes ovis infection and its control with an ivermectin controlled-release capsule on growing sheep. Veterinary Parasitology. 91(1-2). 119–128. 8 indexed citations

16.

Rehbein, Steffen, et al.. (2000). Persistent efficacy of topical eprinomectin against nematode parasites in cattle. Parasitology Research. 86(11). 944–946. 25 indexed citations

17.

Holste, J. E., Douglas D. Colwell, John E. Lloyd, et al.. (1998). Efficacy of eprinomectin against Hypoderma spp in cattle. American Journal of Veterinary Research. 59(1). 56–58. 20 indexed citations

18.

Langholff, Wayne, et al.. (1997). The efficacy of eprinomectin against induced infections of immature (fourth larval stage) and adult nematode parasites in cattle. Veterinary Parasitology. 73(1-2). 119–128. 32 indexed citations

19.

Yazwinski, T. A., Edward G. Johnson, D. R. Thompson, et al.. (1997). Nematocidal efficacy of eprinomectin, delivered topically, in naturally infected cattle. American Journal of Veterinary Research. 58(6). 612–614. 17 indexed citations

20.

Langholff, Wayne, et al.. (1997). Efficacy of a topical formulation of eprinomectin against endoparasites of cattle in New Zealand. New Zealand Veterinary Journal. 45(1). 1–3. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact